AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CDH10 | Cadherin 10, type 2 (T2-cadherin) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CECR6 | Cat eye syndrome chromosome region, candidate 6 | Predicted membrane proteins
| | | | | Group enriched |
CLVS2 | Clavesin 2 | | | | | | Group enriched |
CNTNAP2 | Contactin associated protein-like 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| | | | | Group enriched |
DLX1 | Distal-less homeobox 1 | Transcription factors
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NTNG2 | Netrin G2 | Predicted secreted proteins
| | | | | Group enriched |
NWD1 | NACHT and WD repeat domain containing 1 | | | | | | Group enriched |
RP11-664D7.4 | HCG1787533; Uncharacterized protein | | | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted secreted proteins
| | | | | Group enriched |
TMEFF2 | Transmembrane protein with EGF-like and two follistatin-like domains 2 | Predicted membrane proteins
| | | | | Group enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
ACOXL | Acyl-CoA oxidase-like | | | | | | Group enriched |
AL109927.1 | HCG2032222; PRO2047; Uncharacterized protein | | | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
CFC1 | Cripto, FRL-1, cryptic family 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
CYP4F31P | Cytochrome P450, family 4, subfamily F, polypeptide 31, pseudogene | | | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HOXD13 | Homeobox D13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| | | | | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
LRTM1 | Leucine-rich repeats and transmembrane domains 1 | Predicted membrane proteins
| | | | | Group enriched |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
MYBPH | Myosin binding protein H | | | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | | | | | | Group enriched |
PABPC1L2B | Poly(A) binding protein, cytoplasmic 1-like 2B | | | | | | Group enriched |
PLA2G4D | Phospholipase A2, group IVD (cytosolic) | Enzymes RAS pathway related proteins
| | | | | Group enriched |
POTEE | POTE ankyrin domain family, member E | Plasma proteins
| | | | | Group enriched |
POTEH | POTE ankyrin domain family, member H | Predicted membrane proteins
| | | | | Group enriched |
POTEI | POTE ankyrin domain family, member I | | | | | | Group enriched |
POTEJ | POTE ankyrin domain family, member J | | | | | | Group enriched |
PRAC1 | Prostate cancer susceptibility candidate 1 | | | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC39A2 | Solute carrier family 39 (zinc transporter), member 2 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
TTC6 | Tetratricopeptide repeat domain 6 | | | | | | Group enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |